By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Daeduck BioCommunity
461-6 Jeonmin-dong, Yusung-gu
Taejon    305-390  Korea
Phone: 82-42-866-9300 Fax: 82-42-866-9301



Company News
CrystalGenomics And Standigm, Agree To Collaborate On Utilizing Artificial Intelligence And Structure-Based Drug Design Technologies In Drug R&D 5/30/2017 12:36:12 PM
Aptose Biosciences And CrystalGenomics Announce Exclusive Agreement For Non-Covalent BTK / FLT3 / AURK Inhibitor 6/8/2016 12:20:34 PM
CrystalGenomics Partners With TR-Pharm For Acelex Commercialization In Turkey And MENA 1/12/2016 7:36:30 AM
CrystalGenomics Partners With Dong-A ST For Acelex Commercialization In Korea 8/13/2015 6:45:29 AM
CrystalGenomics Partners With Daewoong Pharmaceutical For Acelex Commercialization In Korea 2/9/2015 8:57:03 AM
CrystalGenomics Receives MFDS Approval For Acelex® (Polmacoxib) 2/5/2015 2:10:02 PM
CrystalGenomics Release: Polmacoxib Demonstrates Prevention And Treatment Effects In Colorectal Cancer 8/13/2014 12:36:20 PM
CrystalGenomics Nabs $12.8 Million From The Global Pharmaceutical Industry Development Fund 6/25/2014 8:43:42 AM
CrystalGenomics Announces Positive Results Of Phase 3 Trial Of Polmacoxib (CG100649) In Patients With Osteoarthritis 3/13/2014 9:35:26 AM
CrystalGenomics Acquires Hwail Pharmaceutical Co., Ltd. 8/26/2013 9:23:29 AM